Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
Work
Year: 2016
Type: article
Source: Immunity
Institutions Icahn School of Medicine at Mount Sinai, Stanford University, Singapore Immunology Network, Agency for Science, Technology and Research, Yale University +2 more
Cites: 46
Cited by: 1,012
Related to: 10
FWCI: 34.95
Citation percentile (by year/subfield): 99.99
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: green